Advertisement
Screener

ARDELYX, INC. (ARDX) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

ARDELYX, INC. Cash Flow Breakdown

Cash flow breakdown shows where ARDELYX, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $42.48M went out.
  • Fiscal year ended 2025-12-31: from investing, $8.96M went out.
  • Fiscal year ended 2025-12-31: from financing, $54.51M came in.
  • Fiscal year ended 2025-12-31: change in cash, $3.07M came in.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksStaff share taxNew shares soldOtherNot split outChange in cash
2025-12-31-$42.48M-$8.96M$0.00$54.51M*$3.07M
2024-12-31-$44.81M-$18.32M$0.00$106.59M*$43.46M
2023-12-31-$89.72M-$131.25M$0.00$119.24M$27.06M*-$74.67M
2022-12-31-$70.04M$18.41M$0.00$71.63M$3.72M*$23.71M
2021-12-31-$152.55M$50.95M-$106.00K$101.15M-$18.04M*-$18.60M
2020-12-31-$81.44M-$31.44M$0.00$21.05M$1.73M*-$90.10M
2019-12-31-$76.48M$23.37M$0.00$0.00$155.48M*$102.36M
2018-12-31-$70.27M-$29.89M$103.55M*$3.38M
2017-12-31-$65.19M$65.29M$62.00K$623.00K*$785.00K
2016-12-31-$92.53M-$131.08M$190.57M$631.00K*-$32.41M
2015-12-31-$71.84M-$3.45M$74.32M$30.00K$659.00K*-$282.00K
2014-12-31$13.40M-$1.86M$61.24M-$2.00K$72.85M
2013-12-31$1.81M-$278.00K$1.00K-$2.00K$1.53M
2012-12-31$21.98M-$128.00K-$20.00K$290.00K$22.12M

Each quarter (3 month)

Quarter endRunning the businessFrom investingBuybacksStaff share taxNew shares soldOtherNot split outChange in cash
2026-06-30-$6.40M*$22.66M*$49.72M*
2026-03-31-$32.24M-$9.99M$5.44M*-$36.79M
2025-12-31$20.95M*$3.78M*$557.00K*
2025-09-30$365.00K*-$50.51M*$2.81M*
2025-06-30-$25.34M*$34.92M*$49.66M*
2025-03-31-$38.46M$2.85M$1.48M*-$34.12M
2024-12-31$9.81M*-$41.62M*$0.00*$49.31M*
2024-09-30$501.00K*$2.34M*$0.00*$2.70M*
2024-06-30-$19.40M*$23.53M*$0.00*$1.61M*
2024-03-31-$35.72M-$2.57M$0.00$52.97M*$14.68M
2023-12-31-$8.72M*-$29.57M*-$12.00K*$26.00M*
2023-09-30-$21.47M*-$32.70M*$57.16M*$710.00K*
2023-06-30-$14.74M*-$59.21M*$11.37M*
2023-03-31-$44.80M-$9.78M$50.72M-$3.65M
2022-12-31$14.28M*$1.44M*$0.00*$18.78M*
2022-09-30-$25.43M*-$832.00K*$34.37M*
2022-06-30-$31.28M*$15.47M*$12.56M*$9.58M*
2022-03-31-$27.62M$2.33M$5.92M*-$25.35M
2021-12-31-$39.47M*$22.10M*$0.00*$33.96M*-$19.44M*
2021-09-30-$34.59M*$18.13M*$4.74M*
2021-06-30-$34.28M*$8.23M*$28.17M*$543.00K*
2021-03-31-$44.22M$2.48M$34.27M-$6.96M
2020-12-31-$17.59M*-$3.57M*$0.00*$21.05M*
2020-09-30-$19.88M*$9.59M*$0.00*$798.00K*
2020-06-30-$19.02M*$13.42M*$0.00*
2020-03-31-$24.95M-$50.88M$0.00$591.00K*-$75.24M
2019-12-31-$11.14M*-$55.46M*$157.00K*$154.90M*
2019-09-30-$20.61M*$23.45M*$14.00K*
2019-06-30-$27.82M*$25.41M*$5.00K*
2019-03-31-$16.91M$29.98M$2.00K$13.27M
2018-12-31-$18.44M*$22.19M*$3.75M*
2018-09-30-$27.02M*$10.09M*$0.00-$16.74M*
2018-06-30-$18.02M*-$61.04M*$0.00$103.06M*$24.01M*
2018-03-31-$6.80M-$1.14M-$7.64M
2017-12-31$4.70M*$11.22M*$15.93M*
2017-09-30-$19.24M*$14.81M*-$4.18M*
2017-06-30-$23.89M*$16.29M*-$7.58M*
2017-03-31-$26.76M$22.97M-$3.38M
2016-12-31-$26.75M*-$59.23M*-$1.00K*-$85.76M*
2016-09-30-$24.64M*-$71.35M*$109.74M*$13.69M*
2016-06-30-$24.90M*-$295.00K*$0.00*-$25.01M*
2016-03-31-$16.25M-$200.00K$80.84M$64.67M
2015-12-31-$21.60M*-$454.00K*$1.00K*$0.00*-$22.04M*
2015-09-30-$11.80M*-$680.00K*-$332.00K*$0.00*-$12.49M*
2015-06-30-$30.22M*-$1.26M*$21.00K*$74.68M*$43.22M*
2015-03-31-$8.21M-$1.05M$296.00K-$8.97M
2014-12-31-$3.79M*-$1.03M*$0.00*-$2.00K*-$4.76M*
2014-09-30-$5.68M*-$88.00K*$0.00*$0.00*-$5.77M*
2014-06-30$23.99M*-$642.00K*$84.59M*
2014-03-31-$1.12M-$94.00K-$1.21M
2013-12-31$10.91M*$0.00*$0.00*$10.91M*
2013-09-30-$199.00K*-$21.00K*-$221.00K*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Avalo Therapeutics, Inc. (AVTX)United States$0.842B-9.74
Immix Biopharma, Inc. (IMMX)United States$0.837B-18.44
Cryoport, Inc. (CYRX)United States$0.881B-21.29
Theravance Biopharma, Inc. (TBPH)$0.885B16.40
Obsidian Therapeutics, Inc. (OBX)United States$0.829B
LEXICON PHARMACEUTICALS, INC. (LXRX)United States$0.823B-17.48
RIGEL PHARMACEUTICALS INC (RIGL)United States$0.893B2.25
GYRE THERAPEUTICS, INC. (GYRE)United States$0.818B-24.71
Apnimed, Inc. (APMD)United States$0.899B
GERON CORP (GERN)United States$0.803B-12.14